Category Archives: Stem Cell Treatment


Stem-cell therapy: The medicine of the future – Ynetnews

In one of the famous scenes of American animated sitcom Family Guy, which was aired on January 2008, the main character, Peter Griffin, is seen entering a stem cell research lab with half his body paralyzed, as a result of a stroke, and walking out completely healthy.

Growing a heart on a plate (PR photo)

Imagination plays an important role in dealing with stem cells. Theoretically, cells that, in a lab, can differentiate into any specialized cell present countless options of playing with the human bodyfrom treating any physical medical failure, through preparing a bank of human spare parts, to producing a new race of perfect human beings, completely flawless and immune. That is only in theory, however, at least at this stage. In practice, the possibilities inherent in stem cells are still imaginary, and using them for actual treatment is still very limited.

Torontos skyline is dotted with multi-story buildings, each with a series of elevators that fly visitors within second from the ground floor to the upper floors. The 35th floor of Eaton Centre, a shopping mall and office complex located near Dundas Squarewhich locals say is like Times Square, only a lot less impressiveoverlooks almost all parts of the Ontario provinces capital.

Using stem cells for the sake of humanity (Illustration photo: Shutterstock)

The most fascinating research has to do with cardiology. This is the field in which the ability to imagine a new era in the near future appears most palpable. Its difficult to overstate the complexity of the human heart, which is made up of different types of cells and tissues and is activated through a sequence of electrical pulses. Modern medicine has been unsuccessful so far in creating an industrial alternative for the heart, at least not one that allows a quality of life, while transplant surgery suffers from the risks of transplant rejection and a regular donor shortage. These limitations, in addition to the fact that heart diseases are very common and are one of the leading causes of death around the world, make cardiology a fertile ground for an industry of innovative medicine.

PR photo

One field in which this vision has already become a reality, at least partially, is lung therapy. Stem cell medicine holds a potential in terms of lungs suitable for transplantation, when it comes to improving of the chances that the new body wont reject the organ. The entire process, however, is complicated. Lung transplantation is only possible when the person who agreed to donate his organs in advance is declared brain dead, which makes it possible to harvest the organs before the entire body collapses, and these are pretty specific cases. In addition, in this group only 20 percent of the donated lungs are eventually transplantedas the procedure must be quick, and in most cases doctors dont have sufficient information about the lungs condition and the ability to prepare it for a transplantation which wont be rejected.

PR photo

In the stem-cell therapy labs in Toronto, the future is both present and absent. Most researchers refuse to fall into the press trap and talk about a vision for a better future in which every problem will be treated by injecting stem cells. And although the phrase growing a heart on a plate is occasionally heard, they make sure to clarify that such a situation is still far off. Nevertheless, no one will deny that stem-cell therapy is the medicine of the future.

The combination of medical and technological innovations may have brought humanity to the start of a new era, in which it will be possible to cure the body in an immensely more efficient way than in the past. But even these accomplishments highlight how little we know about the human body and how much more we need to learn and work in order to be able to unlock the full potential hiding deep within our cells.

(Translated and edited by Sandy Livak-Furmanski)

Go here to see the original:
Stem-cell therapy: The medicine of the future - Ynetnews

Stem cell transplants offer hope for sufferers of gut disorders – Medical Xpress

March 29, 2017 by Elisabeth Lopez Enteric neurosphere in mice. Credit: Wikimedia

After a baby is born, a souvenir of its months in the womb is usually not long to follow. Its first poo, or meconium, is a lump sum of everything the foetus has ingested for months; a dark sludge, compared by the insomniac readers of parenting forums to engine oil or tar.

That first stool is probably the ground zero for Dad jokes. But if it hasn't emerged after 48-72 hours, doctors know to start looking for Hirschsprung Disease. Although rare, affecting one in 5000 live births, Hirschsprung's effects can be debilitating and lifelong, including bowel obstructions, constipation, reflux and vomiting.

"The muscles in the gut wall of these babies are not doing their job, which is to push food through the intestines, because the gut nerves are missing. The milk accumulates, their bellies get distended and the effect is like blocking the end of a fire hose," says developmental neurobiologist Professor Heather Young, of the University of Melbourne.

Professor Young's lab is exploring the potential for stem cell transplants to treat Hirschsprung's Disease, and other disorders of the gut's nervous system. In a recently published article, the team extracted stem cells from healthy parts of the bowel, grew them in a dish (these tiny balls, called neurospheres, measure one fifth of a millimetre, requiring some very fine forceps), and transplanted them back into sections of the gut wall that are missing neurons in Hirschsprung disease.

Currently, the only treatment for Hirschsprung's is surgery, which, while lifesaving, is usually followed by complications and psychosocial issues from problems such as soiling.

"For kids with the most severe form of the disease, life is really tough. They're on a feeding tube and total parenteral (intravenous) nutrition for the rest of their lives," Professor Young says.

The research team, based at the University, the Florey Institute and Queen's University in Canada, is investigating what happens when the development of the gut nerves, or enteric nervous system, is derailed, causing disorders like Hirschsprung's. Often called the 'second brain', this extensive network of 500 million neurons (five times the number of neurons in the spinal cord) controls digestion and excretion.

Our gut neurons are responsible for gut motility, or peristalsis the muscular spasms that push food from the stomach, into the intestines and out through the anus. And researchers are now also exploring its influence on mood and behaviour, and links with conditions such as autism and even some forms of epilepsy. .

When things go well, the enteric nervous system rumbles away in the background, beyond conscious control or awareness (barring the odd tummy ache). But when things go awry, the effects can be devastating.

The gut odyssey

Like all epic stories, the story of the gut nervous system begins with a massive migration.

Gut neurons start life as stem cells located near the base of the developing brain. Making their way from the neural tube into the developing gut tube, they then colonise the entire gastrointestinal tract. Once there, many of them differentiate into nerve cells that make the muscles in the gut wall relax, while some differentiate into nerve cells that are responsible for contractions. Others, known as interneurons, are the middlemen that connect those movements into a rhythm.

"Think of the East coast of Australia as the gastrointestinal tract, with Cairns the oesophagus and Melbourne the . . .ahem . . .other end," explains Lincon Stamp, from Prof Young's laboratory.

"Imagine people migrating down the coast in their cars, all from top to bottom. Normally some make it all the way to Melbourne, with others stopping off to set up homes in cities along the way. However, sometimes the people destined for Melbourne run out of fuel and are stranded further up the coast.

"In Hirschsprung disease this is due to genetic defects some random, some inherited which cause the migrating cells to run out of fuel, leaving them stranded and the last part of the bowel unoccupied."

Most infants are diagnosed with Hirschsprung before they leave hospital, but if only a small region of the bowel is affected, the condition might not be picked up for weeks or months. Surgeons will often remove the affected section of bowel and reattach what's left.

"When neurons in your bowel are diseased or damaged, they're really challenging conditions for gastroenterologists to treat. There are currently no drug treatments," says Dr Stamp.

Gut motility disorders also strike later in life, but these ones tend to affect specific subpopulations of nerves much as Parkinson's disease affects a specific type of brain neuron. By contrast, childhood disorders are usually defined by a total absence of neurons in sections of the bowel or the entire organ.

One increasingly common adult condition is gastroparesis, which is associated with uncontrolled diabetes, Parkinson's disease, and MS. Another is achalasia, characterised by the loss of neurons that enable the sphincter to open and close the oesophagus. It mainly affects elderly people, and is a kind of mirror image to the popular complaint of gastrointestinal reflux, where stomach acid leaks out and up from the oesophagus. Only in achalasia, the oesophagus fails to open at all.

"They can't swallow solids they end up living on soup and liquids. They can choke because the sphincter is not opening," Professor Young says.

Completing the migration

The work by Lincon Stamp and his team on an animal model of Hirschsprung disease is essentially about completing that disrupted migratory journey of stem cells from the brain to the bowel.

"We've shown that they migrate and colonise a reasonably good area of the bowel after the transplant," says Dr Stamp.

"We've been able to transplant cells that survive four months, while another group in the UK has achieved 24 months."

The transplanted cells not only survive they look and behave like neurons.

"Stem cell therapy for a gut motility disorder requires neurons that don't just fire they have to connect with the muscle in the gut wall, to control the relaxation and contractions that move food through," Dr Stamp says.

A new technique called optogenetics enabled the team to confirm the transplanted neurons were behaving as they should. Optogenetics involves inserting light-sensitive proteins, derived from green algae and called opsins, into neurons. The opsins activate the neurons. The team recorded the results to check for signals from the muscles. (Before opsins came on the scene around 2008, neuroscientists could only use electrodes to control neurons).

One of the challenges for the Young lab is isolating gut stem cells in humans and gathering them in sufficient numbers for transplantation. One UK lab has developed technique to make this much easier via routine endoscopies, opening the way to future patient-derived stem cell treatments.

"While a stem cell therapy for humans with gut motility disorders is likely still years away, this study is an exciting leap forward in progress toward that goal," Dr Stamp said.

Explore further: A gut feeling about neural stem cells

More information: Lincon A. Stamp et al. Optogenetic Demonstration of Functional Innervation of Mouse Colon by Neurons Derived From Transplanted Neural Cells, Gastroenterology (2017). DOI: 10.1053/j.gastro.2017.01.005

Proper function of the digestive system requires coordinated contraction of the muscle in the wall of the intestinal tract, regulated by the enteric nervous system. Damage or loss of these neurons can result in intestinal ...

Researchers led by the Francis Crick Institute have developed a zebrafish model of a human disease - Hirschsprung disease - that enables them to study the disease's causes and consequences in living animals and will help ...

A study by scientists at Children's Hospital Los Angeles has shown that tissue-engineered colon derived from human cells is able to develop the many specialized nerves required for function, mimicking the neuronal population ...

Numerous human diseases, including inflammatory bowel disease, diabetes and autism spectrum disorders have been linked to abnormal gut microbial communities, or microbiomes, but an open question is whether these altered microbiomes ...

The enteric nervous system (ENS), the "little brain" that resides within the gut wall, governs motility, secretion, and blood flow in the human gastrointestinal tract. Failure of the ENS to develop normally leads to congenital ...

Genetic studies in humans, zebrafish and mice have revealed how two different types of genetic variations team up to cause a rare condition called Hirschsprung's disease. The findings add to an increasingly clear picture ...

A newly approved drug that is the first to reflect the current scientific understanding of multiple sclerosis (MS) is holding new hope for the hundreds of thousands Americans living with the disease.

With more than 130,000 victims nationwide, strokes are among the leading causes of death in the U.S. each year. According to the Centers for Disease Control (CDC), someone in the United States has a stroke every 40 seconds, ...

After a baby is born, a souvenir of its months in the womb is usually not long to follow. Its first poo, or meconium, is a lump sum of everything the foetus has ingested for months; a dark sludge, compared by the insomniac ...

Tech billionaire Elon Musk is announcing a new venture called Neuralink focused on linking brains to computers.

New research from scientists at the University of Sussex has taken a major step towards unlocking the secrets of hypnosis and gathering evidence that suggests that subjects aren't faking the effects of it.

Older adults who have been scammed by friends, relatives or strangers seem to behave just like elders who have avoided rip-offs. They are able to balance their checkbooks. They can remember and evaluate information. Their ...

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

View original post here:
Stem cell transplants offer hope for sufferers of gut disorders - Medical Xpress

Is Alzheimer’s treatment of injecting stem cells into the brain a breakthrough or quackery? – Quad-Cities Online

IRVINE, Calif. More than eight years after, as he described it, My brain went ... Whats the word? ... Foggy, Jack Sage said finally, four years after he was diagnosed with Alzheimers disease and two years since he began an innovative and extremely invasive therapy, Sage said he is being flooded by memories that seem new, or, at the very least, feel easier to retrieve.

His daughter, Kate, thought Sage suddenly had begun to open up about his past because he knew his time was growing short.

He should not know who I am at this point, Kate said.

His doctor, Christopher Duma, hopes Jack Sage goes down in history as the one-man turning point in the treatment of Alzheimers disease, while others are skeptical about what Duma has done to Sages brain.

The Alzheimers Association reported that 610,000 Californians 65 or older had the disease in 2016, and it estimated increases to 690,000 by 2020 and 840,000 by 2025.

On a cool recent night, Sage, a fit 82-year-old, sat next to his wife Gloria talking about his children (It is significant that Sage remembers their names James, 46, Kate, 50, and Kelly, 56), recalling when he and Gloria moved into their Newport Beach house (1990), their first date (1979), his years as a labor negotiator and executive (1970s and '60s) and the jack hammering he did in the nickel mines (mid-1950s) in Northern Ontario, Canada.

At this point in his illness, his doctor said he should be having more trouble remembering the mine. Sages series of recollections represent the three main components of long-term memory: semantic (recalling the meaning of words), episodic (recalling autobiographic milestones) and procedural (recalling how to accomplish tasks) prompted a grin from Duma, the brain surgeon who, for $10,000 per treatment and without insurance coverage, cut a hole in the back of Sages head and injected a stem cell serum that had been sucked out of Sages love handles.

Is this the Alzheimers breakthrough the world has been waiting for? Or, is this unproven medical procedure what University of Minnesota bioethicist Leigh Turner calls quackery and flimflam? Is this an unsafe, money-grab being conducted outside the approval process of the Food and Drug Administration preying on the most vulnerable among us?

Turner has written extensively and critically about the Cell Surgical Network (CSN), for which Duma, whose home hospital is Hoag in Newport Beach, is listed as a network physician. The CSN promotes the stem cell revolution, which its literature claims, is an appropriate treatment for people suffering from a variety of inflammatory and degenerative conditions, such as cancer, diabetes, bad knees and hips as well as multiple uses in cosmetic surgery.

You dont just start dumping things into peoples brains, Turner said. People may spend a lot of money and find there is no benefit. He (Duma) is exposing people to serious harm. Fat cells dont belong in peoples brains.

Sage is the first patient in Phase I of a clinical study officially called Intracerebroventricular injection of autologous abdominal fat-derived, non-genetically altered stem cells. Sage was the first Alzheimers patient anywhere to have his own liposuctioned cells injected directly into his brain. He has received eight injections (about two months apart) since November 2014.

Duma quickly offers a qualifier. It is far too early to tell if what he has done to Sage will indeed change the world. He said Sage and, later, 19 other patients have not been harmed by the procedure, and that safety is the only criteria in Phase I. Whether the treatment is effective is a question for Phase II, for which Duma is hoping to attract private funding. Also, he wrote a letter to the national Alzheimers Association asking for $700,000 to continue his work. He was instructed to apply officially later this year. If he gets the grant, the fees for his patients would be waived.

So far, Duma is excited by Sages results. Sages most recent cognition scores have risen from 45 on the 100-point Memory Performance Index in March 2015 to 54 in September 2015. The volume of his hippocampus the memory center of the brain has grown from the fifth percentile before his first treatment to the 28th percentile after his fourth treatment to the 48th percentile after his eighth treatment.

Sages brain isnt his only problem. He has a long history of heart ailments that have required the insertion of 12 stents to keep his arteries open.

You cant make a global conclusion based on one patient, but its a huge turning point, Duma said, with the confidence of someone who probes brains for a living.

Duma is somewhat of a maverick in the medical world, a brain surgeon who regularly shuns a scalpel for the gamma knife, a futuristic laser for removing brain tumors.

Duma realizes he will face opposition to his stem cell/brain injection therapy. But, as in all breakthroughs, someone has to be first.

I could have harmed people, he said. I took an enormous leap.

Duma said he is nearly finished writing a paper about his work that he hopes will be published in a peer-reviewed journal.

View post:
Is Alzheimer's treatment of injecting stem cells into the brain a breakthrough or quackery? - Quad-Cities Online

Stem Cell Treatment Has Potential to Help Parkinson’s Disease Unexpected Brain Area – Benzinga

Currently symptomatic therapies for Parkinson's Disease (PD) produce unwanted side effects and diminished effectiveness over time. A recent study published in STEM CELLS suggests that human neural stem cell (hNSC) transplantation could help to treat PD by stimulating subventricular zone (SVZ) stem cells to produce more neural cells.

Durham, NC (PRWEB) March 28, 2017

Currently symptomatic therapies for Parkinson's Disease (PD) produce unwanted side effects and diminished effectiveness over time. A recent study published in STEM CELLS suggests that human neural stem cell (hNSC) transplantation could help to treat PD by stimulating subventricular zone (SVZ) stem cells to produce more neural cells.

Strategies involving transplantation of these cells into the affected brain regions hold great promise; however, the exact mechanisms behind hNSCs' success are not fully understood.

Neural stem cells are self-renewing and can differentiate into any type of neural cell, such as neurons and glial cells. With their ability to rescue dysfunctional neural pathways, NSCs are an ideal source for grafting and the development of novel therapies.

A team led by Renzhi Wang from Peking Union Medical College Hospital and Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences presented an animal model study to improve understanding of the pathogenesis of PD. They also reported that the novel mechanism of action of transplanted hNSCs may prove helpful in the development of stem cell-based therapeutics for PD and other neurodegenerative diseases.

Using a high-throughout quantitative approach, proteome profiles of PD-related brain regions were characterized in mice. These included the substantia nigra, striatum, olfactory bulb, and, significantly, the subventricular zone (SVZ). This analysis showed a profound disturbance of the SVZ proteome, confirming the involvement of the SVZ in PD.

###

The full article, "Intrastriatal transplantation of human neural stem cells restores the impaired subventricular zone in parkinsonian mice," can be accessed at: http://onlinelibrary.wiley.com/doi/10.1002/stem.2616/full.

About the Journal: STEM CELLS, a peer reviewed journal published monthly, provides a forum for prompt publication of original investigative papers and concise reviews. The journal covers all aspects of stem cells: embryonic stem cells/induced pluripotent stem cells; tissue-specific stem cells; cancer stem cells; the stem cell niche; stem cell epigenetics, genomics and proteomics; and translational and clinical research. STEM CELLS is co-published by AlphaMed Press and Wiley-Blackwell.

About AlphaMed Press: Established in 1983, AlphaMed Press with offices in Durham, NC, San Francisco, CA, and Belfast, Northern Ireland, publishes three internationally renowned peer-reviewed journals with globally recognized editorial boards dedicated to advancing knowledge and education in their focused disciplines. STEM CELLS (http://www.StemCells.com) is the world's first journal devoted to this fast paced field of research. THE ONCOLOGIST (http://www.TheOncologist.com) is devoted to community and hospital-based oncologists and physicians entrusted with cancer patient care. STEM CELLS TRANSLATIONAL MEDICINE (http://www.StemCellsTM.com) is dedicated to significantly advancing the clinical utilization of stem cell molecular and cellular biology. By bridging stem cell research and clinical trials, SCTM will help move applications of these critical investigations closer to accepted best practices.

About Wiley-Blackwell: Wiley-Blackwell is the international scientific, technical, medical, and scholarly publishing business of John Wiley & Sons, with strengths in every major academic and professional field and partnerships with many of the world's leading societies. Wiley-Blackwell publishes nearly 1,500 peer-reviewed

For the original version on PRWeb visit: http://www.prweb.com/releases/2017/03/prweb14186331.htm

Continue reading here:
Stem Cell Treatment Has Potential to Help Parkinson's Disease Unexpected Brain Area - Benzinga

Symposium discusses latest and future of stem cell therapy – The Pasadena Star-News

DUARTE>> Dozens of doctors, scientists, businesses and others gathered at City of Hope Thursday for the second California Institute for Regenerative Medicine (CIRM), Alpha Stem Cell Clinics symposium.

CIRM, the states stem cell agency, has developed a network of Alpha Stem Cell Clinics that focus on innovative stem cell-based therapies. The network of three clinics are located at City of Hope, University of California, San Diego, and UCLA/UC Irvine campuses.

The event served as a way for clinics to share their most recent advancements and successes in stem cell therapy clinical trials, and even hear directly from patients who benefited from some of the trials.

We want to review the trials, but we also want to see what other questions we should be asking, said Dr. John Zaia, the Aaron Miller and Edith Miller Chair in Gene Therapy, and director of the Center for Gene Therapy and principal investigator of City of Hopes Alpha Stem Cell Clinic. How will insurance companies charge or pay for these treatments? How do companies plan to develop these treatments? The symposium provides an opportunity to think about these other aspects.

There were also panel speakers who offered more of a motivational talk, such as Pat Furlong, founding president of Parent Project Muscular Dystrophy, discussing how to remove stakeholder barriers to stem cell therapy treatment.

Furlong had to become her and her sons own advocate when they were diagnosed with Duchenne Muscular Dystrophy at a young age. She found there was no standard of care for the disease and no studies or trials in progress to find a treatment, let alone a cure.

Families just didnt know the questions to ask, she said. At the time, few people cared about rare diseases.

After years of no real hope and losing her sons at 15 and 17 years old, with her and her groups persistence, Furlong said there are now 40 companies researching the disease and millions of dollars have gone into research specifically for Duchenne.

City of Hopes Dr. Behnam Badie, chief of neurosurgery and director of the Brain Tumor Program, and Christine Brown, Ph.D., Heritage Provider Network Professor in Immunotherapy and associate director of the T Cell Therapeutics Research Laboratory, discussed their recent successful treatment of a patient with recurrent multifocal glioblastoma using CAR-T cell therapy.

The case study for this unique type of immunotherapy on the most aggressive form of brain cancer was published in the Dec. 29 edition of the New England Journal of Medicine.

Advertisement

In the Phase I clinical trial, the patient, who did not respond to other types of therapy including radiation and even developed tumors in his brain and spinal cord, was treated with his own genetically modified chimeric antigen receptor (CAR) T cells, injected directly into the tumor and through the ventricular system. The patient experienced remission over 8 months.

City of Hope is one of a few cancer centers in the nation offering studies in CAR-T cell therapy, and is the only cancer center investigating CAR-T cells targeting the specific receptors more common in a majority of glioblastomas.

Dr. Badie and Brown noted that working with CIRM has been instrumental in helping them along with their trial, and not just the funding.

You cant create a good trial without studying the product, said Brown. These are expensive trials. We have to treat these patients and understand what is going on.

Go here to read the rest:
Symposium discusses latest and future of stem cell therapy - The Pasadena Star-News

Erectile dysfunction: Stem cell therapy restores sexual function in phase I trial – Medical News Today

Early results of a clinical trial suggest that stem cell therapy may be a promising treatment for erectile dysfunction, after the procedure was found to restore sexual function in men with the condition.

The stem cell therapy involves injecting the patients' own stem cells - derived from abdominal fat cells - into the erectile tissue of the penis.

Lead researcher Dr. Martha Haahr, of Odense University Hospital in Denmark, and colleagues found that within 6 months of the procedure, 8 of the 21 men treated were able to engage in spontaneous sexual intercourse.

The researchers recently presented their findings at EAU17 - the European Association of Urology's annual conference - held in London in the United Kingdom.

Erectile dysfunction (ED) is a condition whereby a man has difficulties getting or maintaining an erection in order to engage in sexual intercourse.

According to the National Institute of Diabetes and Digestive Kidney Diseases, around 12 percent of men under the age of 60, and 22 percent of men aged between 60 and 69, have ED.

High blood pressure, diabetes, heart disease, chronic kidney disease, and prostate surgery are some of the physical conditions that can cause ED. Psychological issues - such as anxiety, stress, depression, and low self-esteem - can also contribute to ED.

Current treatments for ED include PDE5 inhibitors (such as Viagra), penile implants, and injections. However, Dr. Haahr and team note that all of these therapies can have significant side effects.

As a result, researchers are on the hunt for alternative treatments for ED, and stem cell therapy has emerged as a promising candidate in animal trials.

In their phase I trial, Dr. Haahr and colleagues tested stem cell therapy on 21 men who had ED as a result of undergoing radical prostatectomy for prostate cancer. None of the men had responded to standard medical treatment for ED.

For the stem cell procedure, abdominal fat cells were extracted from each man through liposuction. Stem cells were then isolated from the fat cells and injected into the corpus cavernosum of the penis - the spongy tissue that normally becomes filled with blood during an erection.

Before the stem cell procedure and 6 and 12 months after, the participants' erectile function was assessed using the International Index of Erectile Function (IIEF) questionnaire. An IIEF score of 5-7 represents severe erectile dysfunction, 12-16 is mild to moderate erectile dysfunction, and 22-25 is no erectile dysfunction.

All 21 men saw their erectile function improve with stem cell therapy: their IIEF score increased from 6 prior to treatment to 12 at 6 months after treatment.

Eight of the men reported that they had been able to engage in spontaneous sexual activity 6 months after stem cell therapy, and this outcome remained evident at 12 months after treatment. These men saw their IIEF score rise from 7 to 14 with stem cell therapy.

"What we have done establishes that this technique can lead to men recovering a spontaneous erection - in other words, without the use of other medicines, injections, or implants," says Dr. Haahr.

Although the study findings are preliminary, the team says that they show promise for stem cell therapy as an effective treatment strategy for ED.

"We are the first to use a man's own fat stem cells as a treatment for erectile dysfunction in a clinical trial. The technique has been trialed in animal work, but this is the first time stem cell therapy has allowed patients to recover sufficient erectile function to enable intercourse," says Dr. Haahr.

"We are pleased with the preliminary outcomes, especially as these men had previously seen no effect from traditional medical treatment and continue to have good erectile function after 12 months follow-up, indicating that this might be a long-term solution.

This suggests the possibility of therapeutic options for patients suffering from erectile dysfunction from other causes. But we need to remember that this is a small trial, with no control group. We're still some time away from a clinically available solution."

Dr. Martha Haahr

The researchers are now in the process of initiating a phase II trial to further investigate the safety and efficacy of stem cell therapy for ED.

Learn how eating more fruits could help to lower the risk of ED.

Originally posted here:
Erectile dysfunction: Stem cell therapy restores sexual function in phase I trial - Medical News Today

Man with 45% burns healed with stem cell treatment – ETHealthworld.com

Mumbai: A 45-year-old man -- suffering from 45 per cent burns due to a chemical spill at work -- has been healed with stem cell treatment, said the authorities at a hospital here on Friday.

Ram Naik (name changed) was brought to city-based StemRx Bioscience hospital after receiving first aid in another hospital. Nearly 45 per cent of his upper body was burned due to a chemical spill during work.

The impact of the burns led to a charred look on his face and body. Also, joint mobility due to the burns was reduced. The outer layer of the skin was affected, facial burns were of grade II level and in some instances grade III burns were also present, leading to deeper structures like the subcutaneous tissue also being affected.

According to the doctors, burn wound healing involves a series of complex processes, with healing time and scar tissue being the most important parameters that affect treatment outcomes. Burn injuries, especially severe ones, are proving to have devastating effects on the affected patients.

They said that stem cells have been recently applied in burn wounds to promote superior healing of the wounds. Not only have stem cells been shown to promote better and faster healing of the burn wounds, they are also capable of decreasing inflammation and prevent scar progression and fibrosis.

Therefore, the doctors decided to provide Naik stem cell treatment.

Regenerative Medicine researcher at Stemrx Bioscience hospital Pradeep Mahajan said that within two days, a notable improvement in his condition was observed and the swelling and charred appearance started reducing.

"Mild eyelid movements were noticed and on the third day the burns started drying on the face and he could open his mouth and eyes. Growth factors derived from platelets, cells, fibroblasts, collagen-based gel etc. was used during treatment. In addition, in areas with deep burns, sheets of PGLA coated with cells and growth factors were used," said Mahajan, adding that different medication and treatments were imparted and closed dressing was avoided.

"Blood transfusion and supplementary fluids were given intravenously to maintain systemic homeostasis," said Mahajan.

Stating that on 5th and 6th day following treatment, dry scales from the face and body started peeling off, the doctor's team also observed impressive changes such as new skin forming within a week of treatment with cells and growth factors.

By conventional modalities, it takes more than eight weeks for the patient to heal and many additional months for the patient to be able to regain joint and facial movements.

"By the 10th day of the treatment, dry scales completely peeled off and by the 14th day the patient had no tenderness or burning pain. Joint movements became free as well, Steady rate of progression of healthy skin formation is being noticed. Areas with deep burns are also healing at a rapid rate and I am confident that within a month we will accomplish thorough healing and the patient will be back to normal," Mahajan said.

Medical sciences say that such cases are challenging to manage considering the degree of impairment they result in due to prolonged healing period. Also, through conventional therapeutic modalities healing occurs with scar formation and results in contractures. Chances of systemic complications and infection are also high.

However according to the medical team, by using stem cells, the natural healing potential of the body is used, leading to reduction of healing time and promoting regeneration of affected tissues. This also reduces the mental trauma and financial burden that a patient goes through when under conventional management.

"Stem cell-based therapy has offered a novel and powerful strategy in almost every medical specialty including burns and wound management. Stem cells have proven to have tremendous potential in enhancing wound healing and facilitating skin regeneration," Mahajan said.

Go here to read the rest:
Man with 45% burns healed with stem cell treatment - ETHealthworld.com

Inside Green Bay area’s first stem cell clinic – WBAY

HOWARD, Wis. (WBAY) - After two car accidents left her with serious pain in her neck, back, legs and shoulders, Cindy Kastelic says she was starting to lose hope.

"I'd go to the chiropractor, then I'd go in for myofascial release and acupuncture, and sometimes I would go and spend $150, and within an hour it's like I was hurting again, I just wasted all that money."

Three months ago, Kastelic saw an ad for amniotic stem cell treatment and attended a seminar.

She immediately signed up for a treatment to her neck and lower back.

"Amazing that I could move my neck without being in pain, I could sleep on my left or right side without waking up with a kink in my neck, and my lower back started feeling better.," Kastelic said.

"This isn't something that just popped up overnight. This treatment has been going on for years and years and years," Northwoods Family Physical Medical Clinic director Kim Scarlassara said.

Based in Iron River, Mich., Northwoods Family Physical Medicine just opened a clinic in Howard based, it says, on demand from patients suffering from degenerative joint issues.

"Stem cells are the body's master cells," Scarlassara explained. "They have the ability to become basically any other type of cell in your body, like a bone cell, a ligament cell, a cartilage cell. They have the ability to help your body rebuild, repair and regenerate."

Kastelic was back at the clinic Friday for a stem cell treatment to her knees and shoulders.

She calls it a life-changing procedure without the need for surgery or medication.

Diana Hardy of Northwoods Family Physical Medicine said, "I think overall people don't want any more surgeries and that expense and that risk and side effects and medications, pain medications."

Read the original post:
Inside Green Bay area's first stem cell clinic - WBAY

Wandiligong MS sufferer undergoes stem cell treatment in India – The Border Mail

23 Mar 2017, 4:30 p.m.

A Wandiligong MS sufferer has started treatment she hopes will change her life

LOCKDOWNS, an asthma attackand 17 million stem cells have formed part of a Wandiligong womans ongoing medical experience in India.

Emma Bennett and her mother Gail are now unable to leave Artemis Hospital in Gurgaon for seven days as part of the hematopoietic stem cell transplantation (HSCT).

Miss Bennett, who has multiple sclerosis, could not access this procedure in Australia and so her family and community raised about $45,000 to make her trip possible.

Ms Bennett said on Thursday her daughter was in her third day of chemotherapy after the medical team retrieved 17 million stem cells earlier this week.

That was good, now they finish the chemo then reintroduce her own cells and hopefully that will go well, she said.

We have had hundreds of messagesfrom home and we have your readers to thank as well for getting us here.

Emmas sister Penny, speaking from her Wangaratta workplace, said the trip encountered a problem when a planned wheelchair on arrival didnt eventuate.

To the familys relief, airline staff provided extra assistance, staying with the pair as they went through customs and security and then helping them find an English-speaking taxi driver.

The day after flying into Delhi, Miss Bennett and her mother visited the Taj Mahal.

That was Emmas one request because when she was younger she used to travel a lot and (MS) put a stop to that, Penny said.

Early in the trip Ms Bennett suffered an asthma attack, possibly brought on by stress and pollution, but the hospital staff cared for her as well as her daughter.

Penny said Miss Bennetts treatment had produced some side effects, such as fever chills and not feeling well.

Nothing has stopped her eating yet, but knowing my sister, nothing will, Penny said with a laugh.

Im probably still very nervous for the next few sections because chemo is a huge thing for anybody, but the doctors are saying its going really well.

They seem like they quite genuinely really care and theyre being really good with her and she seems quite happy, its been good.

Miss Bennetts progress can be followed on the Ems MS Journey Facebook page while donations can still be made at gofundme.com/ems-ms-journey.

More:
Wandiligong MS sufferer undergoes stem cell treatment in India - The Border Mail